TRANSlational Cancer Oesophagus Gefitinib study (TRANS-COG)
Not Applicable
Completed
- Conditions
- Cancerpper Gastro-Intestinal CancerMalignant neoplasm of oesophagus
- Registration Number
- ISRCTN32435732
- Lead Sponsor
- niversity of Aberdeen (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1. Patients with oesophagogastric cancer must be eligible for and enrolled in the COG trial
2. Ability to provide written informed consent
3. Formalin-fixed and paraffin-embedded (FFPE) tumour material available
4. Male and female participants
5. Lower Age Limit 18 years
Exclusion Criteria
1. Patients not enrolled in COG trial
2. Inability to provide written informed consent
3. No FFPE tumour material available for analysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method